
Chronic kidney disease of unknown origin
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
Showing 261 - 280 of 392 results
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
An commercial technical consultant with ANSTO, based at the Clayton Campus, Dr Robert Acres collaborates with industry partners to improve products and processes within small to large enterprises and acro
Research represents significant step towards developing vaccine
The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.
ANSTO recognised the contribution of individuals and teams to nuclear science and technology at the 2023 ANSTO Awards Ceremony held on 25 July.
Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.
The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.
This program explores the mechanism and outcome of the interaction of radiation on biological systems in order to improve our understanding of the impact of radiation on the brain, optimise radiotherapy and develop mitigation strategies for space travellers.
ANSTO has made two public submissions to parliamentary inquiries with another to be submitted in February 2020 on matters relating to nuclear technologies, their peaceful applications, and the nuclear fuel cycle.
Dr Anna Paradowska has been appointed as a Conjoint Professor of Practice in Advanced Structural Materials at the University of Sydney.
Dr Michelle Jones-Lennon leads the delivery of the Capital Portfolio for the Nuclear Science & Technology group across both Lucas Heights and Clayton campuses of ANSTO. She is also the Program Director for the BRIGHT Pr
ANSTOs capabilities are ideally suited for these investigations relating to quantum technologies.
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.